Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftaroline versus vancomycin + aztreonam for complicated skin and skin structure infection
2006-005283-47Phase 3Completed
- Sponsor
- Cerexa
- Start
- Nov 2006
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Complicated skin and skin structure infection (cSSSI) and skin and soft tissue infections (SSTIs) comparing Ceftaroline with Vancomycin + aztreonam (2 arms). Started Nov 2006; status: completed.
02
Drugs
ceftaroline fosamilvancomycinaztreonam
03
Conditions
Complicated skin and skin structure infection (cSSSI)skin and soft tissue infections (SSTIs)
Beyond the preview
Go deeper on 2006-005283-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005283-47.